Pigment-Tan-Safety Study of a Light-based Home Device for Hair Removal in Adult Subjects
1 other identifier
interventional
21
1 country
1
Brief Summary
This studies was designed to investigate the importance of skin type and UV-exposure on side effects after exposure to an Intense Pulsed Light Home-use device. 21 healthy subjects will receive 8 UV-exposures on one buttock and subsequently three weekly IPL-exposures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started Apr 2012
Typical duration for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2012
CompletedFirst Submitted
Initial submission to the registry
December 20, 2012
CompletedFirst Posted
Study publicly available on registry
January 9, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2013
CompletedJuly 31, 2015
July 1, 2015
1.5 years
December 20, 2012
July 30, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in skin reaction development
Redness, edema, pigment changes, texture changes, blisters and crusting
Immediately after, 1 hr after, 16-24 hrs after, 1 week and 4 weeks after IPL exposure
Secondary Outcomes (1)
Pain
Immediately after IPL exposure (approx. 2 min)
Other Outcomes (1)
mRNA expression of pigment markers
16-24 hrs after the first IPL exposure
Study Arms (1)
IPL after UV-exposure
EXPERIMENTAL8 UV-exposures followed by 3 weekly IPL exposures
Interventions
Eligibility Criteria
You may qualify if:
- Healthy, over 18 years, no childbearing potential, signed informed consent, no moles,tattoos, freckles or scars in the test-area, skin type II-IV
You may not qualify if:
- disease in test-area, prior treatment to IPL, taking drugs interfering with the immune system
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bispebjerg Hospital
Copenhagen, Bispebjerg, 2400, Denmark
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD.
Study Record Dates
First Submitted
December 20, 2012
First Posted
January 9, 2013
Study Start
April 1, 2012
Primary Completion
October 1, 2013
Study Completion
October 1, 2013
Last Updated
July 31, 2015
Record last verified: 2015-07